Affinity Asset Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100
Closed -$802 99
2024
Q2
$802 Buy
+100
New +$1.07K ﹤0.01% 98
2023
Q1
Sell
-375,000
Closed -$2.4M 87
2022
Q4
$2.4M Buy
+375,000
New +$2.93M 1.1% 33
2022
Q3
Hold
0
78
2022
Q2
Hold
0
66
2022
Q1
Sell
-20,000
Closed -$382K 74
2021
Q4
$382K Sell
20,000
-130,000
-87% -$2.86M 0.16% 53
2021
Q3
$3.7M Buy
150,000
+50,000
+50% +$1.18M 1.47% 26
2021
Q2
$2.6M Buy
100,000
+75,400
+307% +$1.96M 1.24% 28
2021
Q1
$779K Buy
24,600
+5,000
+26% +$207K 0.38% 55
2020
Q4
$909K Buy
+19,600
New +$778K 0.56% 43

Other funds holding IOVA